Drug development from bench 2 bedside
VectorB2B was established in 2019 as an organisation for research, innovation, and development.
VectorB2B shareholders are a strong and complementary set of renowned academic and industrial partners within the Portugal health sector – Together we form a robust asset of Knowledge and Innovation.
Based on high-level scientific and technological knowledge, from Discovery to Clinical Trials, including Toxicology (GLP or non-GLP), Manufacturing as well as R&D Portfolio Management and Functional Service Providing, at VectorB2B you can find your ideal partner.
We speed up your development program by CRO fully integrated services delivered by a team of excellence.
VectorB2B can provide fully flexible, tailored solutions based on continuous project management to meet your needs, time schedule and budget.
